(Q33778395)

English

Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential i

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential i (English)

1 reference

Europe PubMed Central

29 July 2017

confidentiality

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Excess mortality

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Andrew John Lees

7

object named as

A J Lees

1 reference

Europe PubMed Central

29 July 2017

author name string

Y Ben-Shlomo

1

1 reference

Europe PubMed Central

29 July 2017

A Churchyard

2

1 reference

Europe PubMed Central

29 July 2017

J Head

3

1 reference

Europe PubMed Central

29 July 2017

B Hurwitz

4

1 reference

Europe PubMed Central

29 July 2017

P Overstall

5

1 reference

Europe PubMed Central

29 July 2017

J Ockelford

6

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 April 1998

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

316

1 reference

Europe PubMed Central

29 July 2017

1191-1196

1 reference

Europe PubMed Central

29 July 2017

7139

1 reference

Europe PubMed Central

29 July 2017

Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

4 July 2018

Selegiline and mortality in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

4 July 2018

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

4 July 2018

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Parkinson's disease is rarely a primary cause of death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

4 July 2018

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

4 July 2018

Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

4 July 2018

How common is dementia in Parkinson's disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

4 July 2018

Accuracy of diagnosis on death certificates compared with that in hospital records

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

4 July 2018

Accuracy of clinical diagnosis in parkinsonism--a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

4 July 2018

Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

4 July 2018

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

30 October 2018

Parkinson's, Alzheimer's, and motor neurone disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

30 October 2018

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Causes of death need confirmation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

30 October 2018

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. "On treatment" rather than intention to treat analysis should have been used

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28519

30 October 2018

Unstable disability and the fluctuations of frailty

1 reference

https://pubmed.ncbi.nlm.nih.gov/9583926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9583926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9583926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom

1 reference

https://pubmed.ncbi.nlm.nih.gov/9583926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selegiline and mortality in Parkinson's disease: another view.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9583926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9583926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.316.7139.1191

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33778395&oldid=1988670484"